InnovaHealth Partners led a $20m Series B round in Materna Medical.

InnovaHealth Partners, a private equity firm, led a $20m Series B round in Materna Medical, a medical device company, with participation from GLIN Impact Capital, Wealthing VC Club, Citrine Angels, Wavemaker Three-Sixty Health, Kimera Limited, Women's Venture Capital Fund and Golden Seeds. "As we celebrate the addition of these new funds to our investment team, we are also excited to announce the new commercial name for our second product, Ellora (formerly Materna Prep), aiming to transform the standard of care in labor and delivery. Over 20 of the top hospitals in the US have been incredible partners in the EASE trial for Ellora, which will be the basis of our FDA De Novo submission this summer," Tracy MacNeal, Materna Medical CEO.